Department of Ophthalmology, St. Martinus-Krankenhaus Düsseldorf, Gladbacher Str. 26, 40219, Düsseldorf, Germany.
Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2639-2647. doi: 10.1007/s00417-022-05569-x. Epub 2022 Feb 3.
To determine the predictability of success and the risk of open conjunctival revision in the subsequent eye after XEN45 Gel Stent implantation according to lens status.
This was a retrospective single-centre study involving 132 eyes of 66 participants who had undergone intraocular pressure (IOP)-lowering XEN45 Gel Stent implantation, either as a standalone procedure in phakic and pseudophakic eyes or in combination with phacoemulsification. Successful surgery was defined by three scores: IOP at follow-up < 21 mmHg (score A) or < 18 mmHg (score B) and an IOP reduction > 20% or IOP ≤ 15 mmHg and an IOP reduction ≥ 40% (score C). In all scores, one open conjunctival revision was allowed, and additional repeat surgery was considered a failure. The predictability of success and revision rate depending on the outcome of the first eye were calculated using Bayes' theorem.
IOP-lowering did not differ significantly between the first and second eyes. Success rates of standalone surgery in the second eye after successful surgery in the first eye significantly exceed rates after prior failure. For the combined procedure, the rates did not differ significantly. For score A, we determined a 76.6% chance of success following a prior success and a 57.9% chance, if prior surgery failed. The corresponding probabilities were 75% and 59.1% for score B, while 66.7% and 15.7% for score C, respectively. We calculated a 60% risk for revision surgery in the standalone phakic group. If the first eye was not revised, the risk of revision in the subsequent eye was 20%. The corresponding risks were 72.7% and 5% for the standalone procedure in pseudophakic patients and 38.4% and 41.7% for the combined procedure, respectively.
The results of our study offer a tool to predict the outcome of subsequent eye surgeries based on either the outcome in the initial eye and the type of surgery performed, owing to the high predictive potential.
根据晶状体状态,确定 XEN45 凝胶支架植入后后续眼手术成功的预测性和开放结膜修正的风险。
这是一项回顾性单中心研究,涉及 66 名参与者的 132 只眼,这些参与者接受了降眼压 XEN45 凝胶支架植入术,这些手术在有晶状体眼和无晶状体眼中是独立进行的,或者与超声乳化白内障吸除术联合进行。成功的手术定义为三个评分:随访时眼压 < 21mmHg(评分 A)或 < 18mmHg(评分 B),眼压降低 > 20%或眼压 ≤ 15mmHg 和眼压降低 ≥ 40%(评分 C)。在所有评分中,允许进行一次开放结膜修正,如果需要再次手术则视为失败。使用贝叶斯定理计算根据第一只眼的结果预测成功的可能性和修正率。
第一只眼和第二只眼的眼压降低没有显著差异。第一只眼手术成功后,第二只眼进行独立手术的成功率明显高于手术失败后的成功率。对于联合手术,成功率没有显著差异。对于评分 A,我们确定了先前成功后成功的可能性为 76.6%,而先前手术失败后的可能性为 57.9%。相应的概率分别为 75%和 59.1%,对于评分 B,66.7%和 15.7%,而对于评分 C。我们计算了在独立有晶状体眼组中进行修正手术的 60%风险。如果第一只眼未进行修正,随后眼进行修正手术的风险为 20%。如果第一只眼未进行修正,那么在后续眼进行修正手术的风险分别为 72.7%和 5%,对于无晶状体眼患者的独立手术,风险分别为 38.4%和 41.7%,对于联合手术。
我们的研究结果提供了一种工具,可以根据初始眼的结果和手术类型,预测后续眼手术的结果,因为其具有很高的预测潜力。